Fredericksburg Free Lance Star Pfizer to start testing its Covid-19 vaccine in children as young as 12 Northern Virginia • Oct 14, 2020
Franklin News Post | Rocky Mount Pfizer to start testing its Covid-19 vaccine in children as young as 12 Blue Ridge Highlands • Oct 14, 2020
Times-Dispatch | Business The Latest: Pfizer modifies protocol for virus vaccine study Virginia Business • Oct 12, 2020
Times-Dispatch | Business The Latest: Pfizer looks at vaccine with fewest side effects Virginia Business • Aug 20, 2020
Virginia Chamber of Commerce Pfizer and BioNTech Choose Lead mRNA Vaccine Candidate Against COVID-19 and Commence Pivotal Phase 2/3 Global Study Virginia Business • Jul 28, 2020
Virginia Chamber of Commerce Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 study of mRNA-based Vaccine Candidate Against SARS-CoV-2 Virginia Business • Jul 2, 2020
Virginia Chamber of Commerce Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program Virginia Business • May 12, 2020
Virginia Business.com DXC Technology elects former Pfizer CEO as board chairman Virginia Business • Feb 10, 2020
Times-Dispatch | Business Nucor, Whirlpool rise; Harley-Davidson, Pfizer fall Virginia Business • Jan 28, 2020
Times-Dispatch | Business Pfizer posts Q4 loss, misses Street views, on lower revenue Virginia Business • Jan 28, 2020
Times-Dispatch | Business Booze Allen Hamilton rises; Pfizer, Cooper Tire fall Virginia Business • Jul 29, 2019
Times-Dispatch | Business Pfizer posts big 2Q profit jump, announces deal with Mylan Virginia Business • Jul 29, 2019
Times-Dispatch | Business Pfizer, Mylan strengthen ties, create new company Virginia Business • Jul 29, 2019
Times-Dispatch | Business Pfizer to absorb Mylan, creating generic giant Virginia Business • Jul 29, 2019
Times-Dispatch | Business Pfizer will absorb Mylan, a $10 billion generic pharmaceutical company that is one of the biggest in the world Virginia Business • Jul 29, 2019
Times-Dispatch | Business Pfizer to buy Array BioPharma in deal worth $11.4 billion Virginia Business • Jun 17, 2019
Times-Dispatch | Business Pfizer is buying the cancer treatment company Array BioPharma in a deal worth more than $11 billion Virginia Business • Jun 17, 2019
Times-Dispatch | Business Pfizer 1Q profit jumps 9% on higher drug sales, lower costs Virginia Business • Apr 30, 2019
Times-Dispatch | Business Biopharmaceuticals power Pfizer in the first quarter Virginia Business • Apr 30, 2019
Times-Dispatch | Business Pfizer swings to loss due to restructuring, asset writedowns Virginia Business • Jan 29, 2019
Times-Dispatch | Business Weak outlook from Pfizer overshadows 4Q performance Virginia Business • Jan 29, 2019